NEW HAVEN, CONNECTICUT, USA, January 9, 2024 /EINPresswire.com/ -- Vita Health, the first provider of clinically validated suicide prevention through innovative care management, announced today the close of a $22.5M Series A funding round.
The funding will support the rapid expansion of life-saving services targeting youth and adults nationwide. The Vita behavioral health care pathways are based on the founding team’s successful clinical trials published in JAMA, The American Journal of Psychiatry and thousands of patient encounters demonstrating reductions in suicide attempts by more than 60% and deaths by up to 80%.
In this episode of the CU Anschutz 360 podcast, Daniel LaBarbera, PhD, director of the Center for Drug Discovery, talks about harnessing technology and innovation to speed the development of new therapies. He discusses robotic automation, quantum computing and building bridges over the ‘valley of death.’
NASHVILLE, Tenn.--(BUSINESS WIRE)--Reimagine Care, the nation’s leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in education and healthcare, are proud to announce a poster presentation at the prestigious 2023 American Society of Hematology (ASH) Annual Meeting and Exposition.